KNSA
Kiniksa Pharmaceuticals Ltd.
$37.24
-$0.65(-1.72%)
66
Overall
40
Value
83
Tech
76
Quality
Market Cap
$2.81B
Volume
192.87K
52W Range
$17.82 - $39.43
Target Price
$47.13
Key Metrics Overview
| Market Cap | $2.81B | P/E Ratio | 36.16 |
| 52W High | $39.43 | 52W Low | $17.82 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | 36.1% | 52W Position | 89.9% |
| Overall Score | 66 | Value Score | 40 |
| Quality Score | 76 | Technical Score | 83 |
Growth Analysis
| EPS Current Est | $1.03 | EPS Next Est | $1.6 |
| EPS Growth Est | +55.3% | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KNSA | $37.24 | -1.7% | 192.87K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Kiniksa Pharmaceuticals Ltd. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW